Degenerative Disc Disease Treatment Market Poised to Hit $37.41 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Degenerative Disc Disease Treatment Market Size Growth Forecast: What to Expect by 2025?
Over the past few years, there has been a significant expansion in the market size for degenerative disc disease treatment. The market is projected to escalate from $27.07 billion in 2024 to $28.79 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Various factors have contributed to this growth in the preceding years, including an increase in the aging population, sedentary lifestyle prevalence, advancements in medical technology, heightened awareness, a surge in obesity rates, a rise in sports-related injuries, and expanded access to healthcare.

How Will the Degenerative Disc Disease Treatment Market Size Evolve and Grow by 2029?
The market for treating degenerative disc disease is projected to see robust growth in the forthcoming years. The market size is set to reach $37.41 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.8%. The anticipated growth within this forecasted period is mainly due to the rise in healthcare spending, an increased need for minimally invasive procedures, improved patient education, broadening clinical research, and an upward trend in spine disorders worldwide. Key emerging trends within this period encompass the merge of AI and machine learning, growth in regenerative medicine, progress in minimally invasive surgery, the emergence of wearable technology, 3D printing for tailor-made implants, the rise of telemedicine and remote consultations, and an emphasis on individualized medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/degenerative-disc-disease-treatment-global-market-report

What Drivers Are Propelling the Growth of Degenerative Disc Disease Treatment Market Forward?
The increase in sports-related injuries is predicted to boost the growth of the market for degenerative disc disease treatment. Such injuries to sports personnel or physically active individuals could be due to sudden impacts, overuse or incorrect techniques, and often lead to physical damage or trauma. The heightened rate of these injuries could be attributed to factors like amplified participation, rigorous training and a strong focus on competitive performance. Treatment for degenerative disc disease is employed in sports injuries to control chronic back pain and rejuvenate function when disc degeneration affects athletes' performance and mobility. For example, in November 2023, Howden Group Holdings Ltd, a UK-based insurance intermediary company, stated that injuries reported in October 2022 resulted in sports players being out of action for an average of 11.35 days prior to tournaments, which extended to 19.41 days by January 2023. Hence, the surge in sports injuries is fuelling the growth of the market for degenerative disc disease treatment.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18784&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Degenerative Disc Disease Treatment Market?
Leading enterprises in the degenerative disc disease treatment market are prioritizing the development of innovative therapies such as injectable disc cell therapy (IDCT). The purpose of these advancements is to enhance patient results by increasing disc volume, easing lower back discomfort, and minimizing reliance on pain-relief drugs. The regenerative remedy, IDCT, is designed to address symptomatic lumbar degenerative disc illnesses. For example, in February 2023, the US-based biopharmaceutical firm DiscGenics Inc. was granted an FDA regenerative medicine advanced therapy designation for its IDCT aimed at treating symptomatic lumbar degenerative disc disease. This pioneering therapy makes use of a live progenitor cell population sourced from donated adult human intervertebral disc tissue. The proposed potential of IDCT includes an increase in disc volume, relief from lower back pain, and reduced dependency on pain medications for those affected.

What Are the Key Segments in the Degenerative Disc Disease Treatment Market?
The degenerative disc disease treatment market covered in this report is segmented -

1) By Type: Conventional Drugs, Novel Therapies
2) By Route Of Administration: Oral, Injectable
3) By End User: Hospitals, Ambulatory Surgical Centers, Orthopedic Center

Subsegments:
1) By Conventional Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Muscle Relaxants, Corticosteroids, Antidepressants
2) By Novel Therapies: Gene Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Biologic Agents, Regenerative Medicine, Cell-Based Therapies, Growth Factor Therapies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18784&type=smp

Who Are the Key Players Shaping the Degenerative Disc Disease Treatment Market's Competitive Landscape?
Major companies operating in the degenerative disc disease treatment market are Pfizer Inc., Johnson And Johnson, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Medtronic plc, Amgen Inc., Baxter International Inc., B. Braun SE, Zimmer Biomet Holdings Inc., Arthrex Inc., Ferring B.V., Biocon Limited, Integra LifeSciences Holdings Corporation, NuVasive Inc., Globus Medical Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., LifeNet Health

What Geographic Markets Are Powering Growth in the Degenerative Disc Disease Treatment Market?
North America was the largest region in the degenerative disc disease treatment market in 2024. The regions covered in the degenerative disc disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18784

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.